JoVE Search Results: Photodynamic Therapy

Impact
Papers
Jobs
Conferences

Name	Impact ?	Papers	Institution	Country	Funding
Hamblin, Michael R	247.7	26	Massachusetts General Hospital	USA	$1,923,880.00
Golab, Jakub	215.5	3	Medical University of Warsaw	Poland	-
Sabatini, David M	198	11	Whitehead Institute for Biomedical Research	USA	$8,465,572.00
Pandey, Ravindra K	130.5	4	Roswell Park Cancer Institute	USA	$5,813,280.00
Guan, Kun-Liang	116.1	7	University of California at San Diego	USA	$8,247,035.00
Hall, Michael N	114.6	8	University of Basel	Switzerland	-
Burgess, Kevin	96.8	2	College Station	USA	$2,451,188.00
Blenis, John	88.7	5	Harvard Medical School	USA	$7,927,669.00
Chi, Hongbo	88.3	5	Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105	USA	$3,355,107.00
Powell, Jonathan D	77.2	7	Johns Hopkins University School of Medicine	USA	$7,207,880.00
Sonenberg, N	71.8	8		N/A	-
Zhang, Yaou	70.9	2	Tsinghua University	China	-
Wulf, H C	69.2	8	University of Copenhagen	Denmark	-
Hasan, Tayyaba	67.4	6	Harvard Medical School	USA	$15,187,250.00
Durand, Jean-Olivier	65.6	5	Laboratoire RÃ©actions et gÃ©nie des ProcÃ©dÃ©s, UPR 3349, Nancy-UniversitÃ©, 1, rue Grandville, 54000, Nancy	France	-
Olivo, Malini	65.3	4	National Cancer Centre, Division of Medical Sciences	Singapore	-
Curnow, A	64.7	10	Royal Cornwall Hospital	UK	-
Korbelik, M	64.3	8	Wayne State University	USA	-
Ruggero, Davide	62.8	2	University of California	USA	$4,325,137.00
Chen, Jie	60.6	12	University of Illinois at Urbana-Champaign	USA	$4,353,532.00
Li, Xiaoxia	57.6	6	Cleveland Clinic Foundation	USA	$8,474,304.00
Blagosklonny, Mikhail V	57.2	11	Roswell Park Cancer Institute	USA	-
Chen, Xiangmei	53.8	3	PLA General Hospital and Military Medical Postgraduate College	China	-
Anderson, R Rox	53.6	6	Harvard Medical School	USA	-
Hortobagyi, Gabriel N	53.3	1	Harvard Medical School	USA	$5,015,622.00
Inoue, Yoshikazu	53.3	1	University of Cincinnati	USA	-
Shah, Manisha H	53.3	1	University of Texas M.D. Anderson Cancer Center	USA	-
Wüthrich, Rudolf P	53.3	1	University Hospital and the University of Zurich	Switzerland	-
Horton, Maureen R	52.8	1	Johns Hopkins University School of Medicine	USA	-
Hopper, Colin	51.1	5	University College Hospital	UK	-
Weiss, William A	49	4	University of California	USA	$9,918,314.00
Shrikant, Protul A	48.6	3	Roswell Park Cancer Institute	USA	-
Maytin, Edward V	47.4	5	Cleveland Clinic	USA	$3,137,436.00
Awazu, Kunio	47.4	4	Graduate School of Engineering	Japan	-
Yang, Yunsheng	46.8	2	Chinese PLA General Hospital	China	-
Huang, Shile	46.7	11	Louisiana State University Health Sciences Center	USA	$403,994.00
Zhang, Hongbing	46.4	6	Chinese Academy of Medical Sciences & Peking Union Medical College	China	-
Snyder, Solomon H	46.1	2	Johns Hopkins University School of Medicine	USA	$34,627,626.00
Chen, Qian	44.9	6	Rhode Island Hospital and Brown University	USA	$18,566,762.00
Ikeda, Norihiko	44.8	3	Tokyo Medical University	Japan	-
Baur, Joseph A	44.3	2	Massachusetts Institute of Technology	USA	$1,594,283.00
Hwang, Kuo Chu	44.2	2	National Tsing Hua University	Taiwan	-
Lai, Ping-Shan	43.2	4	National Taiwan University	Taiwan	-
Narita, Masako	42.9	2	Cambridge Research Institute	UK	-
Huang, Zheng	42.7	7	Shanghai Skin Diseases and STD Hospital	China	-
Agostinis, Patrizia	42.7	5	Catholic University of Leuven	Belgium	-
Robinson, Dominic J	42.3	7	Center for Optical Diagnostics and Therapy, Department of Radiation Oncology, Erasmus MC, Rotterdam, The Netherlands.	Netherlands	-
Gu, Ying	41.9	5	Chinese Academy of Sciences	China	$687,397.00
Hengstschläger, M	41.5	10	Medical University of Vienna	Austria	-
Gomer, Charles J	41.4	4	Children's Hospital Los Angeles	USA	-

Name	Institution	Date	Impact	Publication
Golab, Jakub	Medical University of Warsaw	05/26/2011	101.70	CA: a cancer journal for clinicians Photodynamic therapy of cancer: an update. Abstract
Hortobagyi, Gabriel N	Harvard Medical School	12/07/2011	53.29	The New England journal of medicine Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer. Abstract
Inoue, Yoshikazu	University of Cincinnati	03/16/2011	53.29	The New England journal of medicine Efficacy and safety of sirolimus in lymphangioleiomyomatosis. Abstract
Shah, Manisha H	University of Texas M.D. Anderson Cancer Center	02/10/2011	53.29	The New England journal of medicine Everolimus for advanced pancreatic neuroendocrine tumors. Abstract
Wüthrich, Rudolf P	University Hospital and the University of Zurich	06/26/2010	53.29	The New England journal of medicine Sirolimus and kidney growth in autosomal dominant polycystic kidney disease. Abstract
Horton, Maureen R	Johns Hopkins University School of Medicine	11/29/2011	52.76	Annual review of immunology Regulation of immune responses by mTOR. Abstract
Guan, Kun-Liang	University of California at San Diego	01/30/2013	39.12	Nature reviews. Molecular cell biology Amino acid signalling upstream of mTOR. Abstract
Blenis, John	Harvard Medical School	04/02/2009	39.12	Nature reviews. Molecular cell biology Molecular mechanisms of mTOR-mediated translational control. Abstract
Ruggero, Davide	University of California	02/22/2012	36.28	Nature The translational landscape of mTOR signalling steers cancer initiation and metastasis. Abstract
Yang, Yaping	Texas Children's Hospital	09/29/2013	35.53	Nature genetics Truncating mutations of MAGEL2 cause Prader-Willi phenotypes and autism. Abstract
Chi, Hongbo	Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105	04/20/2012	33.28	Nature reviews. Immunology Regulation and function of mTOR signalling in T cell fate decisions. Abstract
Sabatini, David M	Whitehead Institute for Biomedical Research	04/16/2012	32.40	Cell mTOR signaling in growth control and disease. Abstract
Snyder, Solomon H	Johns Hopkins University School of Medicine	12/14/2010	32.40	Cell Inositol pyrophosphates inhibit Akt signaling, thereby regulating insulin sensitivity and weight gain. Abstract
Sabatini, David M	Whitehead Institute for Biomedical Research	05/14/2009	32.40	Cell DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival. Abstract
Hall, Michael N	University of Basel	02/21/2013	31.20	Science (New York, N.Y.) Quantitative phosphoproteomics reveal mTORC1 activates de novo pyrimidine synthesis. Abstract
Baur, Joseph A	Massachusetts Institute of Technology	03/30/2012	31.20	Science (New York, N.Y.) Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity. Abstract
Sabatini, David M	Whitehead Institute for Biomedical Research	06/10/2011	31.20	Science (New York, N.Y.) The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling. Abstract
Blenis, John	Harvard Medical School	06/10/2011	31.20	Science (New York, N.Y.) Phosphoproteomic analysis identifies Grb10 as an mTORC1 substrate that negatively regulates insulin signaling. Abstract
Narita, Masashi	Cancer Research UK Cambridge Research Institute (CRI)	04/21/2011	31.20	Science (New York, N.Y.) Spatial coupling of mTOR and autophagy augments secretory phenotypes. Abstract
Hall, Michael N	University of Basel	10/31/2011	29.00	Nature reviews. Drug discovery Rapamycin passes the torch: a new generation of mTOR inhibitors. Abstract
Burgess, Kevin	College Station	09/26/2012	28.76	Chemical Society reviews BODIPY dyes in photodynamic therapy. Abstract
Pandey, Ravindra K	Roswell Park Cancer Institute	08/09/2010	28.76	Chemical Society reviews The role of porphyrin chemistry in tumor imaging and photodynamic therapy. Abstract
Weiss, William A	University of California	10/18/2013	26.56	Cancer cell EGFR phosphorylates tumor-derived EGFRvIII driving STAT3/5 and progression in glioblastoma. Abstract
Ruggero, Davide	University of California	03/15/2010	26.56	Cancer cell Genetic dissection of the oncogenic mTOR pathway reveals druggable addiction to translational control via 4EBP-eIF4E. Abstract
Sabatini, David M	Whitehead Institute for Biomedical Research	02/02/2009	26.56	Cancer cell mTOR complex 2 is required for the development of prostate cancer induced by Pten loss in mice. Abstract
Powell, Jonathan D	Johns Hopkins University School of Medicine	02/27/2011	26.00	Nature immunology The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2. Abstract
Chi, Hongbo	Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105	09/19/2010	26.00	Nature immunology The S1P(1)-mTOR axis directs the reciprocal differentiation of T(H)1 and T(reg) cells. Abstract
Zhang, Yong	National University of Singapore	09/16/2012	22.46	Nature medicine In vivo photodynamic therapy using upconversion nanoparticles as remote-controlled nanotransducers. Abstract
Li, Xiaoxia	Cleveland Clinic Foundation	11/08/2012	21.63	Immunity Inactivation of the enzyme GSK3α by the kinase IKKi promotes AKT-mTOR signaling pathway that mediates interleukin-1-induced Th17 cell maintenance. Abstract
Guan, Kun-Liang	University of California at San Diego	10/17/2011	21.63	Annual review of pharmacology and toxicology AMPK and mTOR in cellular energy homeostasis and drug targets. Abstract
Shrikant, Protul A	Roswell Park Cancer Institute	04/22/2011	21.63	Immunity A central role for mTOR kinase in homeostatic proliferation induced CD8+ T cell memory and tumor immunity. Abstract
Li, Xiaoxia	Cleveland Clinic Foundation	01/07/2010	21.63	Immunity The receptor SIGIRR suppresses Th17 cell proliferation via inhibition of the interleukin-1 receptor pathway and mTOR kinase activation. Abstract
Shrikant, Protul A	Roswell Park Cancer Institute	01/07/2010	21.63	Immunity The mTOR kinase determines effector versus memory CD8+ T cell fate by regulating the expression of transcription factors T-bet and Eomesodermin. Abstract
Powell, Jonathan D	Johns Hopkins University School of Medicine	06/22/2009	21.63	Immunity The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment. Abstract
Guan, Kun-Liang	University of California at San Diego	01/17/2013	19.48	Nature cell biology YAP mediates crosstalk between the Hippo and PI(3)K–TOR pathways by suppressing PTEN via miR-29. Abstract
Chen, Xiaoyuan	Nanjing University	02/13/2013	15.41	Advanced materials (Deerfield Beach, Fla.) Single continuous wave laser induced photodynamic/plasmonic photothermal therapy using photosensitizer-functionalized gold nanostars. Abstract
Sonenberg, Nahum	McGill University	08/26/2013	14.73	Neuron Translational control of entrainment and synchrony of the suprachiasmatic circadian clock by mTOR/4E-BP1 signaling. Abstract
Sabatini, David M	Whitehead Institute for Biomedical Research	10/22/2010	14.17	Molecular cell Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress. Abstract
Sonenberg, Nahum	McGill University	03/29/2010	14.17	Molecular cell Postnatal deamidation of 4E-BP2 in brain enhances its association with raptor and alters kinetics of excitatory synaptic transmission. Abstract
Hwang, Kuo Chu	National Tsing Hua University	10/18/2013	13.73	Angewandte Chemie (International ed. in English) Photosensitization of singlet oxygen and in vivo photodynamic therapeutic effects mediated by PEGylated W(18)O(49) nanowires. Abstract
Sabatini, David M	Whitehead Institute for Biomedical Research	08/22/2013	13.66	Cell metabolism A Central role for mTOR in lipid homeostasis. Abstract
Sabatini, David M	Whitehead Institute for Biomedical Research	08/13/2012	13.66	Cell metabolism DEPTOR cell-autonomously promotes adipogenesis, and its expression is associated with obesity. Abstract
Snyder, Solomon H	Johns Hopkins University School of Medicine	02/02/2011	13.66	Cell metabolism Amino acid signaling to mTOR mediated by inositol polyphosphate multikinase. Abstract
Guan, Kun-Liang	University of California at San Diego	04/09/2009	13.66	Cell metabolism Critical role for hypothalamic mTOR activity in energy balance. Abstract
Sonenberg, Nahum	McGill University	04/19/2011	13.50	Cell host & microbe Leishmania repression of host translation through mTOR cleavage is required for parasite survival and infection. Abstract
Chi, Hongbo	Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105	11/25/2013	13.06	The Journal of clinical investigation Tuning mTOR activity for immune balance. Abstract
Baur, Joseph A	Massachusetts Institute of Technology	03/01/2013	13.06	The Journal of clinical investigation Rapalogs and mTOR inhibitors as anti-aging therapeutics. Abstract
Zhang, Hongbing	Chinese Academy of Medical Sciences & Peking Union Medical College	12/28/2009	13.06	The Journal of clinical investigation Mammalian target of rapamycin regulates murine and human cell differentiation through STAT3/p63/Jagged/Notch cascade. Abstract
Hall, Michael N	University of Basel	09/29/2011	12.89	Current opinion in cell biology mTOR signaling in disease. Abstract
Sabatini, David M	Whitehead Institute for Biomedical Research	11/27/2009	12.89	Current opinion in cell biology mTOR and cancer: many loops in one pathway. Abstract
Hall, Michael N	University of Basel	03/02/2009	12.89	Current opinion in cell biology mTOR and the control of whole body metabolism. Abstract
Hall, Michael N	University of Basel	03/21/2012	12.35	Trends in cell biology Bidirectional crosstalk between endoplasmic reticulum stress and mTOR signaling. Abstract
Narita, Masako	Cambridge Research Institute	03/11/2009	11.65	Genes & development Autophagy mediates the mitotic senescence transition. Abstract
Powell, Jonathan D	Johns Hopkins University School of Medicine	08/14/2012	11.14	Immunological reviews mTOR, metabolism, and the regulation of T-cell differentiation and function. Abstract
Guan, Kun-Liang	University of California at San Diego	03/01/2013	10.84	Trends in biochemical sciences Nutrient signaling to mTOR and cell growth. Abstract
Blenis, John	Harvard Medical School	04/30/2011	10.84	Trends in biochemical sciences The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation. Abstract
Gu, Yueqing	China Pharmaceutical University	12/24/2012	10.77	ACS nano In vivo targeted deep-tissue photodynamic therapy based on near-infrared light triggered upconversion nanoconstruct. Abstract
Sabatini, David M	Whitehead Institute for Biomedical Research	06/28/2012	10.35	Trends in molecular medicine Amino acids and mTORC1: from lysosomes to disease. Abstract
Chen, Jie	University of Illinois at Urbana-Champaign	06/21/2010	10.26	The Journal of cell biology Mammalian target of rapamycin regulates miRNA-1 and follistatin in skeletal myogenesis. Abstract
Sonenberg, Nahum	McGill University	05/18/2012	9.81	Proceedings of the National Academy of Sciences of the United States of America Distinct perturbation of the translatome by the antidiabetic drug metformin. Abstract
Hall, Michael N	University of Basel	06/03/2009	9.81	Proceedings of the National Academy of Sciences of the United States of America mTOR complex 2 in adipose tissue negatively controls whole-body growth. Abstract
Chi, Hongbo	Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105	05/28/2013	9.52	Current opinion in immunology mTOR and lymphocyte metabolism. Abstract
Hwang, Kuo Chu	National Tsing Hua University	12/16/2013	8.35	Small (Weinheim an der Bergstrasse, Germany) First demonstration of gold nanorods-mediated photodynamic therapeutic destruction of tumors via near infra-red light activation. Abstract
Lai, Ping-Shan	National Chung Hsing University	04/17/2012	8.35	Small (Weinheim an der Bergstrasse, Germany) Improved photodynamic cancer treatment by folate-conjugated polymeric micelles in a KB xenografted animal model. Abstract
Hamblin, Michael R	Massachusetts General Hospital	09/26/2013	7.86	Cancer research Photodynamic therapy of murine mastocytoma induces specific immune responses against the cancer/testis antigen P1A. Abstract
Sonenberg, Nahum	McGill University	10/24/2012	7.86	Cancer research eIF4E/4E-BP ratio predicts the efficacy of mTOR targeted therapies. Abstract
Maytin, Edward V	Cleveland Clinic	08/01/2011	7.86	Cancer research Vitamin D3 enhances the apoptotic response of epithelial tumors to aminolevulinate-based photodynamic therapy. Abstract
Zhang, Hongbing	Chinese Academy of Medical Sciences & Peking Union Medical College	01/04/2011	7.86	Cancer research Lactate dehydrogenase B is critical for hyperactive mTOR-mediated tumorigenesis. Abstract
Golab, Jakub	Medical University of Warsaw	05/12/2009	7.86	Cancer research Proteasome inhibition potentiates antitumor effects of photodynamic therapy in mice through induction of endoplasmic reticulum stress and unfolded protein response. Abstract
Huang, Shile	Louisiana State University Health Sciences Center	01/27/2009	7.86	Cancer research Curcumin disrupts the Mammalian target of rapamycin-raptor complex. Abstract
Ikeda, Norihiko	Tokyo Medical University	03/23/2010	7.74	Clinical cancer research : an official journal of the American Association for Cancer Research Outcome of photodynamic therapy using NPe6 for bronchogenic carcinomas in central airways >1.0 cm in diameter. Abstract
Maytin, Edward V	Cleveland Clinic	05/15/2009	7.74	Clinical cancer research : an official journal of the American Association for Cancer Research Low-dose methotrexate enhances aminolevulinate-based photodynamic therapy in skin carcinoma cells in vitro and in vivo. Abstract
Hengstschläger, Markus	Medical University of Vienna	06/08/2009	7.64	Human molecular genetics Functional interaction of mammalian target of rapamycin complexes in regulating mammalian cell size and cell cycle. Abstract
Weiss, William A	University of California	11/09/2010	7.50	Science signaling Akt and autophagy cooperate to promote survival of drug-resistant glioma. Abstract
Sabatini, David M	Whitehead Institute for Biomedical Research	04/21/2009	7.50	Science signaling The pharmacology of mTOR inhibition. Abstract
Weiss, William A	University of California	01/27/2009	7.50	Science signaling EGFR signals to mTOR through PKC and independently of Akt in glioma. Abstract
Zhang, Hongbing	Chinese Academy of Medical Sciences & Peking Union Medical College	11/01/2013	7.45	Autophagy MTOR inhibition attenuates DNA damage and apoptosis through autophagy-mediated suppression of CREB1. Abstract
Agostinis, Patrizia	Catholic University of Leuven	06/19/2013	7.45	Autophagy ROS-induced autophagy in cancer cells assists in evasion from determinants of immunogenic cell death. Abstract
Blagosklonny, Mikhail V	Roswell Park Cancer Institute	11/28/2012	7.45	Autophagy Hypoxia, MTOR and autophagy: converging on senescence or quiescence. Abstract
Weiss, William A	University of California	05/01/2011	7.45	Autophagy Autophagy and Akt promote survival in glioma. Abstract
Zhang, Hongjie	Chinese Academy of Sciences (CAS)	07/13/2013	7.40	Biomaterials Graphene oxide covalently grafted upconversion nanoparticles for combined NIR mediated imaging and photothermal/photodynamic cancer therapy. Abstract
Lai, Ping-Shan	National Chung Hsing University	10/12/2012	7.40	Biomaterials Bioluminescence resonance energy transfer using luciferase-immobilized quantum dots for self-illuminated photodynamic therapy. Abstract
Chen, J	University of Wollongong	08/22/2011	7.04	Obesity reviews : an official journal of the International Association for the Study of Obesity Multiple signal pathways in obesity-associated cancer. Abstract
Durand, Jean-Olivier	Laboratoire RÃ©actions et gÃ©nie des ProcÃ©dÃ©s, UPR 3349, Nancy-UniversitÃ©, 1, rue Grandville, 54000, Nancy	02/18/2009	6.72	Chemical communications (Cambridge, England) Mannose-targeted mesoporous silica nanoparticles for photodynamic therapy. Abstract
Guan, Kun-Liang	University of California at San Diego	07/27/2011	6.60	Development (Cambridge, England) An emerging role for TOR signaling in mammalian tissue and stem cell physiology. Abstract
Olivo, Malini	National Cancer Centre, Division of Medical Sciences	03/31/2009	6.57	Cellular and molecular life sciences : CMLS The effect of photodynamic therapy on tumor angiogenesis. Abstract
Chi, Hongbo	Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105	02/01/2013	6.39	Seminars in immunology mTOR and metabolic pathways in T cell quiescence and functional activation. Abstract
Powell, Jonathan D	Johns Hopkins University School of Medicine	01/14/2013	6.39	Seminars in immunology Sensing the immune microenvironment to coordinate T cell metabolism, differentiation & function. Abstract
Zhang, H	Peking Union Medical College and Chinese Academy of Medical Sciences	09/30/2013	6.37	Oncogene Pivotal role of augmented αB-crystallin in tumor development induced by deficient TSC1/2 complex. Abstract
Hengstschläger, M	Medical University of Vienna	05/23/2011	6.37	Oncogene Nucleocytoplasmic localization of p70 S6K1, but not of its isoforms p85 and p31, is regulated by TSC2/mTOR. Abstract
Hengstschläger, M	Medical University of Vienna	11/23/2009	6.37	Oncogene Embryoid body formation of human amniotic fluid stem cells depends on mTOR. Abstract
Huang, Shile	Louisiana State University Health Sciences Center	04/12/2012	5.95	Neoplasia (New York, N.Y.) Rapamycin inhibits lymphatic endothelial cell tube formation by downregulating vascular endothelial growth factor receptor 3 protein expression. Abstract
Durand, Jean-Olivier	Laboratoire RÃ©actions et gÃ©nie des ProcÃ©dÃ©s, UPR 3349, Nancy-UniversitÃ©, 1, rue Grandville, 54000, Nancy	05/25/2010	5.91	Nanoscale Silica-based nanoparticles for photodynamic therapy applications. Abstract
Sonenberg, Nahum	McGill University	01/12/2010	5.83	Chemistry & biology A chemical genetic screen for mTOR pathway inhibitors based on 4E-BP-dependent nuclear accumulation of eIF4E. Abstract
Powell, Jonathan D	Johns Hopkins University School of Medicine	05/04/2012	5.79	Journal of immunology (Baltimore, Md. : 1950) Mammalian target of rapamycin integrates diverse inputs to guide the outcome of antigen recognition in T cells. Abstract
Lai, Ping-Shan	National Chung Hsing University	06/12/2011	5.73	Journal of controlled release : official journal of the Controlled Release Society Dendrimer phthalocyanine-encapsulated polymeric micelle-mediated photochemical internalization extends the efficacy of photodynamic therapy and overcomes drug-resistance in vivo. Abstract
Huang, Shile	Louisiana State University Health Sciences Center	08/08/2013	5.70	Carcinogenesis Dihydroartemisinin inhibits the mammalian target of rapamycin-mediated signaling pathways in tumor cells. Abstract
Chen, Jie	University of Illinois at Urbana-Champaign	06/05/2013	5.56	Journal of lipid research Mechanistic target of rapamycin controls homeostasis of adipogenesis. Abstract
Chen, Qun	South China Normal University	07/06/2011	5.54	European journal of cancer (Oxford, England : 1990) New insights of mitochondria reactive oxygen species generation and cell apoptosis induced by low dose photodynamic therapy. Abstract
Hamblin, Michael R	Massachusetts General Hospital	08/19/2013	5.42	Free radical biology & medicine Thiocyanate potentiates antimicrobial photodynamic therapy: in situ generation of the sulfur trioxide radical anion by singlet oxygen. Abstract
Hamblin, Michael R	Massachusetts General Hospital	10/06/2012	5.42	Free radical biology & medicine Paradoxical potentiation of methylene blue-mediated antimicrobial photodynamic inactivation by sodium azide: role of ambient oxygen and azide radicals. Abstract
Blagosklonny, Mikhail V	Roswell Park Cancer Institute	09/09/2013	5.36	Cell cycle (Georgetown, Tex.) S6K in geroconversion. Abstract
Blagosklonny, Mikhail V	Roswell Park Cancer Institute	08/22/2013	5.36	Cell cycle (Georgetown, Tex.) CDK4/6-inhibiting drug substitutes for p21 and p16 in senescence: duration of cell cycle arrest and MTOR activity determine geroconversion. Abstract
Blagosklonny, Mikhail V	Roswell Park Cancer Institute	09/17/2012	5.36	Cell cycle (Georgetown, Tex.) Hypoxia and gerosuppression: the mTOR saga continues. Abstract
Blagosklonny, Mikhail V	Roswell Park Cancer Institute	12/15/2010	5.36	Cell cycle (Georgetown, Tex.) Increasing healthy lifespan by suppressing aging in our lifetime: preliminary proposal. Abstract
Shrikant, Protul A	Roswell Park Cancer Institute	08/12/2010	5.36	Cell cycle (Georgetown, Tex.) Fine-tuning CD8(+) T cell functional responses: mTOR acts as a rheostat for regulating CD8(+) T cell proliferation, survival and differentiation? Abstract
Blagosklonny, Mikhail V	Roswell Park Cancer Institute	06/21/2009	5.36	Cell cycle (Georgetown, Tex.) At concentrations that inhibit mTOR, resveratrol suppresses cellular senescence. Abstract
Blenis, John	Harvard Medical School	02/18/2009	5.36	Cell cycle (Georgetown, Tex.) Not all substrates are treated equally: implications for mTOR, rapamycin-resistance and cancer therapy. Abstract
Burgess, Kevin	College Station	09/24/2013	5.25	Journal of medicinal chemistry Double-targeting using a TrkC ligand conjugated to dipyrrometheneboron difluoride (BODIPY) based photodynamic therapy (PDT) agent. Abstract
Pandey, Ravindra K	Roswell Park Cancer Institute	09/06/2011	5.25	Journal of medicinal chemistry In vitro cellular uptake and dimerization of signal transducer and activator of transcription-3 (STAT3) identify the photosensitizing and imaging-potential of isomeric photosensitizers derived from chlorophyll-a and bacteriochlorophyll-a. Abstract
Hamblin, Michael R	Massachusetts General Hospital	05/20/2010	5.25	Journal of medicinal chemistry In vitro photodynamic therapy and quantitative structure-activity relationship studies with stable synthetic near-infrared-absorbing bacteriochlorin photosensitizers. Abstract
Pandey, Ravindra K	Roswell Park Cancer Institute	07/16/2009	5.25	Journal of medicinal chemistry Conjugation of 2-(1'-hexyloxyethyl)-2-devinylpyropheophorbide-a (HPPH) to carbohydrates changes its subcellular distribution and enhances photodynamic activity in vivo. Abstract
Blagosklonny, Mikhail V	Roswell Park Cancer Institute	06/13/2012	5.13	Aging Once again on rapamycin-induced insulin resistance and longevity: despite of or owing to. Abstract
Blagosklonny, Mikhail V	Roswell Park Cancer Institute	01/20/2011	5.13	Aging DNA damaging agents and p53 do not cause senescence in quiescent cells, while consecutive re-activation of mTOR is associated with conversion to senescence. Abstract
Blagosklonny, Mikhail V	Roswell Park Cancer Institute	07/07/2010	5.13	Aging The choice between p53-induced senescence and quiescence is determined in part by the mTOR pathway. Abstract
Li, Xuejun	Peking University	11/22/2011	5.08	Molecular oncology Atorvastatin reduces vascular endothelial growth factor (VEGF) expression in human non-small cell lung carcinomas (NSCLCs) via inhibition of reactive oxygen species (ROS) production. Abstract
Hamblin, Michael R	Massachusetts General Hospital	10/29/2012	5.06	Nanomedicine : nanotechnology, biology, and medicine Photoinduced electron-transfer mechanisms for radical-enhanced photodynamic therapy mediated by water-soluble decacationic C₇₀ and C₈₄O₂ Fullerene Derivatives. Abstract
Hamblin, Michael R	Massachusetts General Hospital	11/29/2011	5.06	Nanomedicine (London, England) Photodynamic therapy with fullerenes in vivo: reality or a dream? Abstract
Hamblin, M R	Medical University of Graz	09/24/2013	5.04	British journal of cancer Photodynamic therapy plus regulatory T-cell depletion produces immunity against a mouse tumour that expresses a self-antigen. Abstract
Korbelik, M	Wayne State University	02/19/2009	5.04	British journal of cancer Increased tumour dihydroceramide production after Photofrin-PDT alone and improved tumour response after the combination with the ceramide analogue LCL29. Evidence from mouse squamous cell carcinomas. Abstract
Chen, Jie	University of Illinois at Urbana-Champaign	09/25/2013	4.94	Molecular biology of the cell Distinct amino acid-sensing mTOR pathways regulate skeletal myogenesis. Abstract
Pandey, Ravindra K	Roswell Park Cancer Institute	05/20/2010	4.93	Bioconjugate chemistry Synthesis of Tumor-avid Photosensitizer-Gd(III)DTPA conjugates: impact of the number of gadolinium units in T1/T2 relaxivity, intracellular localization, and photosensitizing efficacy. Abstract
Huang, Shile	Louisiana State University Health Sciences Center	07/13/2010	4.91	Cancer prevention research (Philadelphia, Pa.) Cryptotanshinone inhibits cancer cell proliferation by suppressing Mammalian target of rapamycin-mediated cyclin D1 expression and Rb phosphorylation. Abstract
Blagosklonny, Mikhail V	Roswell Park Cancer Institute	04/02/2010	4.89	The American journal of pathology Rapamycin extends maximal lifespan in cancer-prone mice. Abstract
Hamblin, Michael R	Massachusetts General Hospital	09/19/2011	4.84	Antimicrobial agents and chemotherapy Blue dye and red light, a dynamic combination for prophylaxis and treatment of cutaneous Candida albicans infections in mice. Abstract
Agostinis, Patrizia	Catholic University of Leuven	08/30/2010	4.79	Apoptosis : an international journal on programmed cell death Photodynamic therapy: illuminating the road from cell death towards anti-tumour immunity. Abstract
Lai, Ping-Shan	National Taiwan University	08/02/2010	4.78	Molecular pharmaceutics Reduced skin photosensitivity with meta-tetra(hydroxyphenyl)chlorin-loaded micelles based on a poly(2-ethyl-2-oxazoline)-b-poly(d,l-lactide) diblock copolymer in vivo. Abstract
Chen, Jie	University of Illinois at Urbana-Champaign	10/31/2012	4.77	The Journal of biological chemistry Mammalian target of rapamycin (mTOR) signaling network in skeletal myogenesis. Abstract
Chen, Jie	University of Illinois at Urbana-Champaign	08/18/2011	4.77	The Journal of biological chemistry Raptor and Rheb negatively regulate skeletal myogenesis through suppression of insulin receptor substrate 1 (IRS1). Abstract
Chen, Jie	University of Illinois at Urbana-Champaign	07/07/2011	4.77	The Journal of biological chemistry Phosphatidic acid activates mammalian target of rapamycin complex 1 (mTORC1) kinase by displacing FK506 binding protein 38 (FKBP38) and exerting an allosteric effect. Abstract
Guan, Kun-Liang	University of California at San Diego	08/18/2009	4.75	American journal of physiology. Endocrinology and metabolism Critical roles for the TSC-mTOR pathway in β-cell function. Abstract
Chen, Jie	University of Illinois at Urbana-Champaign	02/03/2009	4.75	American journal of physiology. Endocrinology and metabolism Amino acid-sensing mTOR signaling is involved in modulation of lipolysis by chronic insulin treatment in adipocytes. Abstract
Li, Xuejun	Peking University	01/25/2012	4.63	The international journal of biochemistry & cell biology Atorvastatin sensitizes human non-small cell lung carcinomas to carboplatin via suppression of AKT activation and upregulation of TIMP-1. Abstract
Hasan, Tayyaba	Harvard Medical School	10/11/2012	4.41	Journal of the National Comprehensive Cancer Network : JNCCN Using cellular mechanisms to develop effective combinations of photodynamic therapy and targeted therapies. Abstract
Gomer, Charles J	Children's Hospital Los Angeles	10/11/2012	4.41	Journal of the National Comprehensive Cancer Network : JNCCN Induction of prosurvival molecules during treatment: rethinking therapy options for photodynamic therapy. Abstract
Hamblin, Michael R	Massachusetts General Hospital	08/07/2013	4.34	Journal of biophotonics CpG oligodeoxynucleotide as immune adjuvant enhances photodynamic therapy response in murine metastatic breast cancer. Abstract
Hamblin, Michael R	Massachusetts General Hospital	09/14/2012	4.34	Journal of biophotonics Antimicrobial photodynamic therapy with RLP068 kills methicillin-resistant Staphylococcus aureus and improves wound healing in a mouse model of infected skin abrasion PDT with RLP068/Cl in infected mouse skin abrasion. Abstract
Robinson, Dominic J	Department of Dermatology, Erasmus MC, Rotterdam, The Netherlands.	08/15/2011	4.34	Journal of biophotonics Monitoring blood volume and saturation using superficial fibre optic reflectance spectroscopy during PDT of actinic keratosis. Abstract
Hasan, Tayyaba	Harvard Medical School	05/25/2010	4.34	Journal of biophotonics Monitoring the efficacy of antimicrobial photodynamic therapy in a murine model of cutaneous leishmaniasis using L. major expressing GFP. Abstract
Maytin, Edward V	Cleveland Clinic	07/25/2012	4.24	Cancer letters Biomodulatory approaches to photodynamic therapy for solid tumors. Abstract
Hasan, Tayyaba	Harvard Medical School	01/18/2012	4.24	Cancer letters Epidermal growth factor receptor-targeted photosensitizer selectively inhibits EGFR signaling and induces targeted phototoxicity in ovarian cancer cells. Abstract
Zhang, Hongbing	Chinese Academy of Medical Sciences & Peking Union Medical College	09/12/2011	4.24	Cancer letters TSC1/TSC2 inactivation inhibits AKT through mTORC1-dependent up-regulation of STAT3-PTEN cascade. Abstract
Gomer, Charles J	Children's Hospital Los Angeles	02/19/2011	4.24	Cancer letters Enhancement of photodynamic therapy by 2,5-dimethyl celecoxib, a non-cyclooxygenase-2 inhibitor analog of celecoxib. Abstract
Golab, Jakub	Medical University of Warsaw	10/12/2009	4.24	Cancer letters Photodynamic therapy-driven induction of suicide cytosine deaminase gene. Abstract
Gomer, Charles J	Children's Hospital Los Angeles	09/03/2009	4.24	Cancer letters Targeting the 90 kDa heat shock protein improves photodynamic therapy. Abstract
Korbelik, Mladen	British Columbia Cancer Agency, Vancouver, BC	03/27/2009	4.24	Cancer letters Complement upregulation in photodynamic therapy-treated tumors: Role of Toll-like receptor pathway and NFkappaB. Abstract
Agostinis, Patrizia	Catholic University of Leuven	07/07/2010	4.13	Journal of cellular and molecular medicine Autophagy pathways activated in response to PDT contribute to cell resistance against ROS damage. Abstract
Chen, Xiangmei	PLA General Hospital and Military Medical Postgraduate College	05/08/2013	4.09	PloS one Rapamycin upregulates autophagy by inhibiting the mTOR-ULK1 pathway, resulting in reduced podocyte injury. Abstract
Hamblin, Michael R	Massachusetts General Hospital	06/26/2012	4.09	PloS one Photodynamic therapy can induce a protective innate immune response against murine bacterial arthritis via neutrophil accumulation. Abstract
Chen, Jinfei	Nanjing Medical University	12/19/2011	4.09	PloS one The DNA repair gene APE1 T1349G polymorphism and risk of gastric cancer in a Chinese population. Abstract
Hamblin, Michael R	Massachusetts General Hospital	12/14/2010	4.09	PloS one Photodynamic therapy of tumors can lead to development of systemic antigen-specific immune response. Abstract
Huang, Shile	Louisiana State University Health Sciences Center	05/11/2010	4.09	PloS one Rapamycin inhibits IGF-1 stimulated cell motility through PP2A pathway. Abstract
Olivo, Malini	National Cancer Centre, Division of Medical Sciences	11/02/2009	3.99	Molecular cancer Targeting EGFR with photodynamic therapy in combination with Erbitux enhances in vivo bladder tumor response. Abstract
Anderson, R Rox	Harvard Medical School	07/16/2010	3.99	Journal of the American Academy of Dermatology Photodynamic therapy for acne vulgaris: a critical review from basics to clinical practice: part I. Acne vulgaris: when and why consider photodynamic therapy? Abstract
Maytin, Edward V	Cleveland Clinic	11/20/2009	3.99	Journal of the American Academy of Dermatology Pain associated with aminolevulinic acid-photodynamic therapy of skin disease. Abstract
Chen, Qun	South China Normal University	05/31/2010	3.87	Journal of cellular physiology Inhibitive effects of photofrin on cellular autophagy. Abstract
Agostinis, Patrizia	Catholic University of Leuven	12/23/2011	3.70	Cancer immunology, immunotherapy : CII Hypericin-based photodynamic therapy induces surface exposure of damage-associated molecular patterns like HSP70 and calreticulin. Abstract
Wulf, H C	University of Copenhagen	01/02/2013	3.67	The British journal of dermatology Weather conditions and daylight-mediated photodynamic therapy: protoporphyrin IX-weighted daylight doses measured in six geographical locations. Abstract
Wulf, H C	University of Copenhagen	05/25/2012	3.67	The British journal of dermatology Daylight-mediated photodynamic therapy of moderate to thick actinic keratoses of the face and scalp: a randomized multicentre study. Abstract
Curnow, A	Royal Cornwall Hospital	11/17/2011	3.67	The British journal of dermatology Oxygen saturation and perfusion changes during dermatological methylaminolaevulinate photodynamic therapy. Abstract
Anderson, R Rox	Harvard Medical School	11/17/2011	3.67	The British journal of dermatology Surgical scar remodelling after photodynamic therapy using aminolaevulinic acid or its methylester: a retrospective, blinded study of patients with field cancerization. Abstract
Curnow, A	Royal Cornwall Hospital	05/13/2011	3.67	The British journal of dermatology Comparison of protoporphyrin IX accumulation and destruction during methylaminolevulinate photodynamic therapy of skin tumours located at acral and nonacral sites. Abstract
Wulf, H C	University of Copenhagen	04/05/2011	3.67	The British journal of dermatology A randomized, multicentre study of directed daylight exposure times of 1½ vs. 2½ h in daylight-mediated photodynamic therapy with methyl aminolaevulinate in patients with multiple thin actinic keratoses of the face and scalp. Abstract
Wulf, H C	University of Copenhagen	03/26/2009	3.67	The British journal of dermatology Photodynamic therapy of actinic keratoses with 8% and 16% methyl aminolaevulinate and home-based daylight exposure: a double-blinded randomized clinical trial. Abstract
Huang, Shile	Louisiana State University Health Sciences Center	02/08/2010	3.64	Laboratory investigation; a journal of technical methods and pathology Hydrogen peroxide inhibits mTOR signaling by activation of AMPKalpha leading to apoptosis of neuronal cells. Abstract
Zhang, Yaou	Tsinghua University	09/19/2011	3.54	FEBS letters MiR-143 enhances adipogenic differentiation of 3T3-L1 cells through targeting the coding region of mouse pleiotrophin. Abstract
Chen, Jie	University of Illinois at Urbana-Champaign	09/30/2009	3.54	American journal of physiology. Cell physiology mTOR regulates skeletal muscle regeneration in vivo through kinase-dependent and kinase-independent mechanisms. Abstract
Chen, Jun		12/09/2013	3.53	Molecular pain The mTOR signaling pathway regulates pain-related synaptic plasticity in rat entorhinal-hippocampal pathways. Abstract
Sonenberg, Nahum	McGill University	06/03/2009	3.44	BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy Current status and challenges associated with targeting mTOR for cancer therapy. Abstract
Chen, Xiangmei	PLA General Hospital and Military Medical Postgraduate College	08/19/2009	3.44	Mechanisms of ageing and development Expression and mechanism of mammalian target of rapamycin in age-related renal cell senescence and organ aging. Abstract
Ikeda, Norihiko	Tokyo Medical University	05/23/2009	3.43	Lung cancer (Amsterdam, Netherlands) Breast cancer resistant protein (BCRP) is a molecular determinant of the outcome of photodynamic therapy (PDT) for centrally located early lung cancer. Abstract
Durand, Jean-Olivier	Laboratoire RÃ©actions et gÃ©nie des ProcÃ©dÃ©s, UPR 3349, Nancy-UniversitÃ©, 1, rue Grandville, 54000, Nancy	04/28/2012	3.35	International journal of pharmaceutics Multifunctionalized mesoporous silica nanoparticles for the in vitro treatment of retinoblastoma: Drug delivery, one and two-photon photodynamic therapy. Abstract
Durand, Jean-Olivier	Laboratoire RÃ©actions et gÃ©nie des ProcÃ©dÃ©s, UPR 3349, Nancy-UniversitÃ©, 1, rue Grandville, 54000, Nancy	10/08/2010	3.35	International journal of pharmaceutics Silicalites and Mesoporous Silica Nanoparticles for photodynamic therapy. Abstract
Powell, Jonathan D	Johns Hopkins University School of Medicine	07/16/2009	3.32	Immunology mTOR: taking cues from the immune microenvironment. Abstract
Hengstschläger, M	Medical University of Vienna	07/13/2010	3.25	Amino acids Different cytoplasmic/nuclear distribution of S6 protein phosphorylated at S240/244 and S235/236. Abstract
Hengstschläger, M	Medical University of Vienna	05/13/2010	3.25	Amino acids Evidence for cell cycle-dependent, rapamycin-resistant phosphorylation of ribosomal protein S6 at S240/244. Abstract
Hengstschläger, M	Medical University of Vienna	01/15/2009	3.25	Amino acids mTOR phosphorylated at S2448 binds to raptor and rictor. Abstract
Hengstschläger, M	Medical University of Vienna	04/02/2008	3.25	Amino acids Tuberin, p27 and mTOR in different cells. Abstract
Hall, Michael N	University of Basel	07/18/2013	3.24	Biochemical Society transactions Talks about TORCs: recent advancesin target of rapamycin signalling. On mTOR nomenclature. Abstract
Hall, Michael N	University of Basel	07/18/2013	3.24	Biochemical Society transactions Conserved sequence motifs and the structure of the mTOR kinase domain. Abstract
Sabatini, David M	Whitehead Institute for Biomedical Research	01/15/2009	3.24	Biochemical Society transactions Rag proteins regulate amino-acid-induced mTORC1 signalling. Abstract
Hamblin, Michael R	Massachusetts General Hospital	05/06/2013	3.22	Bioanalysis Synthesis, bioanalysis and biodistribution of photosensitizer conjugates for photodynamic therapy. Abstract
Korbelik, Mladen	British Columbia Cancer Agency, Vancouver, BC	10/26/2012	3.21	Immunobiology Upregulation of genes for C-reactive protein and related pentraxin/complement proteins in photodynamic therapy-treated human tumor cells: enrolment of PI3K/Akt and AP-1. Abstract
Awazu, Kunio	Graduate School of Engineering	10/22/2012	3.16	Journal of biomedical optics In vitro investigation of efficient photodynamic therapy using a nonviral vector; hemagglutinating virus of Japan envelope. Abstract
Awazu, Kunio	Graduate School of Engineering	10/12/2012	3.16	Journal of biomedical optics In vitro investigation of efficient photodynamic therapy using a nonviral vector; hemagglutinating virus of Japan envelope. Abstract
Awazu, Kunio	Graduate School of Engineering	08/16/2012	3.16	Journal of biomedical optics In vitro investigation of efficient photodynamic therapy using a nonviral vector; hemagglutinating virus of Japan envelope. Abstract
Awazu, Kunio	Graduate School of Engineering	06/06/2011	3.16	Journal of biomedical optics Determination of the tumor tissue optical properties during and after photodynamic therapy using inverse Monte Carlo method and double integrating sphere between 350 and 1000 nm. Abstract
Maytin, Edward V	Cleveland Clinic	11/08/2010	3.16	Journal of biomedical optics Noninvasive fluorescence monitoring of protoporphyrin IX production and clinical outcomes in actinic keratoses following short-contact application of 5-aminolevulinate. Abstract
Chen, Qun	South China Normal University	05/12/2010	3.16	Journal of biomedical optics Quantitative measurement of reactive oxygen species in vivo by utilizing a novel method: chemiluminescence with an internal fluorescence as reference. Abstract
Olivo, Malini	National Cancer Centre, Division of Medical Sciences	03/09/2010	3.16	Journal of biomedical optics Evaluation of hypericin-mediated photodynamic therapy in combination with angiogenesis inhibitor bevacizumab using in vivo fluorescence confocal endomicroscopy. Abstract
Hamblin, Michael R	Massachusetts General Hospital	10/12/2012	3.15	ChemMedChem Stable synthetic bacteriochlorins for photodynamic therapy: role of dicyano peripheral groups, central metal substitution (2H, Zn, Pd), and Cremophor EL delivery. Abstract
Hopper, Colin	University College Hospital	12/07/2011	3.14	Head & neck oncology Photodynamic therapy and end-stage tongue base cancer: short communication. Abstract
Huang, Shile	Louisiana State University Health Sciences Center	06/09/2010	3.08	Critical reviews in eukaryotic gene expression mTOR signaling in cancer cell motility and tumor metastasis. Abstract
Hengstschläger, M	Medical University of Vienna	09/09/2009	3.02	European journal of clinical investigation CDKs as therapeutic targets for the human genetic disease tuberous sclerosis? Abstract
Korbelik, Mladen	British Columbia Cancer Agency, Vancouver, BC	09/24/2010	3.01	Cell stress & chaperones Heat shock protein 70 is acute phase reactant: response elicited by tumor treatment with photodynamic therapy. Abstract
Wulf, H C	University of Copenhagen	01/07/2013	2.98	Journal of the European Academy of Dermatology and Venereology : JEADV Daylight-mediated photodynamic therapy of basal cell carcinomas - an explorative study. Abstract
Hamblin, Michael R	Massachusetts General Hospital	01/14/2013	2.97	Biological chemistry Melanoma resistance to photodynamic therapy: new insights. Abstract
Hengstschläger, Markus		03/16/2009	2.92	Leukemia research New insights into the role of the tuberous sclerosis genes in leukemia. Abstract
Powell, Jonathan D	Johns Hopkins University School of Medicine	07/07/2009	2.90	Molecular immunology Enhanced interaction between Hsp90 and raptor regulates mTOR signaling upon T cell activation. Abstract
Huang, Shile	Louisiana State University Health Sciences Center	03/16/2011	2.89	Current protein & peptide science Role of mTOR signaling in tumor cell motility, invasion and metastasis. Abstract
Huang, Shile	Louisiana State University Health Sciences Center	08/30/2010	2.89	Current protein & peptide science The complexes of mammalian target of rapamycin. Abstract
Huang, Shile	Louisiana State University Health Sciences Center	07/29/2013	2.86	Anti-cancer agents in medicinal chemistry Hitting the golden TORget: curcumin's effects on mTOR signaling. Abstract
Huang, Shile	Louisiana State University Health Sciences Center	11/12/2010	2.86	Anti-cancer agents in medicinal chemistry Updates of mTOR inhibitors. Abstract
Yang, Yunsheng	Chinese PLA General Hospital	12/07/2013	2.81	Journal of photochemistry and photobiology. B, Biology The potential of photodynamic therapy to treat esophageal candidiasis coexisting with esophageal cancer. Abstract
Robinson, D J	Department of Dermatology, Erasmus MC, Rotterdam, The Netherlands.	07/11/2013	2.81	Journal of photochemistry and photobiology. B, Biology Topical hexylaminolevulinate and aminolevulinic acid photodynamic therapy: complete arteriole vasoconstriction occurs frequently and depends on protoporphyrin IX concentration in vessel wall. Abstract
Chen, Qian	Rhode Island Hospital and Brown University	08/11/2009	2.81	Journal of orthopaedic research : official publication of the Orthopaedic Research Society The effect of rapamycin on bone growth in rabbits. Abstract
Blagosklonny, Mikhail V	Roswell Park Cancer Institute	11/01/2013	2.64	Cancer biology & therapy Dysregulation of the mTOR pathway in p53-deficient mice. Abstract
Gu, Ying	Chinese Academy of Sciences	05/17/2010	2.62	Mini reviews in medicinal chemistry Towards characteristics of photodynamic drugs specifically aimed at microvascular diseases. Abstract
Gu, Ying	PLA General Hospital	11/08/2013	2.61	Lasers in surgery and medicine Retinal injury thresholds for 532, 578, and 630 nm lasers in connection to photodynamic therapy for choroidal neovascularization. Abstract
Hopper, Colin	University College Hospital	06/15/2013	2.61	Lasers in surgery and medicine Strategies of airway management for head and neck photo-dynamic therapy. Abstract
Hopper, Colin	University College Hospital	07/31/2012	2.61	Lasers in surgery and medicine Long-term outcomes following Foscan®-PDT of basal cell carcinomas. Abstract
Hamblin, Michael R	Massachusetts General Hospital	06/29/2012	2.61	Lasers in surgery and medicine Surface layer-preserving photodynamic therapy (SPPDT) in a subcutaneous mouse model of lung cancer. Abstract
Hasan, Tayyaba	Harvard Medical School	11/07/2011	2.61	Lasers in surgery and medicine Verteporfin-based photodynamic therapy overcomes gemcitabine insensitivity in a panel of pancreatic cancer cell lines. Abstract
Ikeda, Norihiko	Tokyo Medical University	11/07/2011	2.61	Lasers in surgery and medicine Molecular determinants of photodynamic therapy for lung cancers. Abstract
Anderson, R Rox	Harvard Medical School	11/07/2011	2.61	Lasers in surgery and medicine Intracutaneous ALA photodynamic therapy: dose-dependent targeting of skin structures. Abstract
Olivo, Malini	National Cancer Centre, Division of Medical Sciences	11/07/2011	2.61	Lasers in surgery and medicine Antiangiogenesis agents avastin and erbitux enhance the efficacy of photodynamic therapy in a murine bladder tumor model. Abstract
Hamblin, Michael R	Massachusetts General Hospital	11/07/2011	2.61	Lasers in surgery and medicine Photodynamic therapy for infections: clinical applications. Abstract
Gomer, Charles J	Children's Hospital Los Angeles	11/07/2011	2.61	Lasers in surgery and medicine Pro-apoptotic and anti-inflammatory properties of the green tea constituent epigallocatechin gallate increase photodynamic therapy responsiveness. Abstract
Anderson, R R	Harvard Medical School	09/29/2011	2.61	Lasers in surgery and medicine Enhanced uptake and photoactivation of topical methyl aminolevulinate after fractional CO2 laser pretreatment. Abstract
Hamblin, Michael R	Massachusetts General Hospital	04/18/2011	2.61	Lasers in surgery and medicine Photodynamic inactivation of bacteria using polyethylenimine-chlorin(e6) conjugates: Effect of polymer molecular weight, substitution ratio of chlorin(e6) and pH. Abstract
Chen, Qun	South China Normal University	08/31/2010	2.61	Lasers in surgery and medicine Increasing the efficiency of photodynamic therapy by improved light delivery and oxygen supply using an anticoagulant in a solid tumor model. Abstract
Curnow, Alison	Royal Cornwall Hospital	08/31/2010	2.61	Lasers in surgery and medicine The relationship between protoporphyrin IX photobleaching during real-time dermatological methyl-aminolevulinate photodynamic therapy (MAL-PDT) and subsequent clinical outcome. Abstract
Hamblin, Michael R	Massachusetts General Hospital	01/19/2010	2.61	Lasers in surgery and medicine Photodynamic therapy for methicillin-resistant Staphylococcus aureus infection in a mouse skin abrasion model. Abstract
Robinson, Dominic J	Center for Optical Diagnostics and Therapy, Department of Radiation Oncology, Erasmus MC, Rotterdam, The Netherlands.	10/19/2009	2.61	Lasers in surgery and medicine Monitoring interstitial m-THPC-PDT in vivo using fluorescence and reflectance spectroscopy. Abstract
Anderson, R Rox	Harvard Medical School	07/15/2009	2.61	Lasers in surgery and medicine Treatment of hypertrophic and resistant port wine stains with a 755 nm laser: a case series of 20 patients. Abstract
Hasan, Tayyaba	Harvard Medical School	06/22/2009	2.61	Lasers in surgery and medicine Optimization of topical photodynamic therapy with 3,7-bis(di-n-butylamino)phenothiazin-5-ium bromide for cutaneous leishmaniasis. Abstract
Anderson, R Rox	Harvard Medical School	02/24/2009	2.61	Lasers in surgery and medicine Porphyrin distribution after topical aminolevulinic acid in a novel porcine model of sebaceous skin. Abstract
Wulf, Hans Christian	University of Copenhagen	11/14/2013	2.58	Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology Artificial daylight photodynamic therapy with "non-inflammatory" doses of hexyl aminolevulinate only marginally delays SCC development in UV-exposed hairless mice. Abstract
Wulf, Hans Christian	University of Copenhagen	12/13/2012	2.58	Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology People maintain their sun exposure behaviour in a 5-7-year follow-up study using personal electronic UVR dosimeters. Abstract
Robinson, Dominic J	Department of Dermatology, Erasmus MC, Rotterdam, The Netherlands.	10/29/2012	2.58	Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology Light fractionated ALA-PDT enhances therapeutic efficacy in vitro; the influence of PpIX concentration and illumination parameters. Abstract
Hamblin, Michael R	Massachusetts General Hospital	04/09/2011	2.58	Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology Combination approaches to potentiate immune response after photodynamic therapy for cancer. Abstract
Hamblin, Michael R	Massachusetts General Hospital	03/24/2011	2.58	Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology The immunosuppressive side of PDT. Abstract
Chen, Qun	South China Normal University	03/17/2011	2.58	Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology In vivo detection of chemiluminescence to monitor photodynamic threshold dose for tumor treatment. Abstract
Huang, Zheng	Shanghai Skin Diseases and STD Hospital	02/18/2011	2.58	Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology Combination of photodynamic therapy and immunomodulation for skin diseases--update of clinical aspects. Abstract
Korbelik, Mladen	British Columbia Cancer Agency, Vancouver, BC	01/24/2011	2.58	Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology Cancer vaccines generated by photodynamic therapy. Abstract
Agostinis, Patrizia	Catholic University of Leuven	01/24/2011	2.58	Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology DAMPs and PDT-mediated photo-oxidative stress: exploring the unknown. Abstract
Chen, Jianming	Second Military Medical University	07/28/2011	2.55	Bioorganic & medicinal chemistry Synthesis and photobiological study of a novel chlorin photosensitizer BCPD-18MA for photodynamic therapy. Abstract
Robinson, D J	Department of Dermatology, Erasmus MC, Rotterdam	10/15/2013	2.52	Photodiagnosis and photodynamic therapy The effect of light fractionation with a 2-h dark interval on the efficacy of topical hexyl-aminolevulinate photodynamic therapy in normal mouse skin. Abstract
Huang, Zheng	Shanghai Skin Diseases and STD Hospital	04/17/2012	2.52	Photodiagnosis and photodynamic therapy Adverse effects associated with photodynamic therapy (PDT) of port-wine stain (PWS) birthmarks. Abstract
Durand, Jean-Olivier	Laboratoire RÃ©actions et gÃ©nie des ProcÃ©dÃ©s, UPR 3349, Nancy-UniversitÃ©, 1, rue Grandville, 54000, Nancy	01/31/2012	2.52	Photodiagnosis and photodynamic therapy Hyaluronic acid-functionalized mesoporous silica nanoparticles for efficient photodynamic therapy of cancer cells. Abstract
Hopper, Colin	University College Hospital	01/14/2012	2.52	Photodiagnosis and photodynamic therapy Treatment of Kimura disease with photodynamic therapy: a case study. Abstract
Huang, Zheng	Shanghai Skin Diseases and STD Hospital	08/25/2011	2.52	Photodiagnosis and photodynamic therapy Successful treatment of refractory facial acne using repeat short-cycle ALA-PDT: Case study. Abstract
Curnow, Alison	Royal Cornwall Hospital	12/17/2010	2.52	Photodiagnosis and photodynamic therapy Monitoring the accumulation and dissipation of the photosensitizer protoporphyrin IX during standard dermatological methyl-aminolevulinate photodynamic therapy utilizing non-invasive fluorescence imaging and quantification. Abstract
Curnow, Alison	Royal Cornwall Hospital	11/05/2010	2.52	Photodiagnosis and photodynamic therapy Protoporphyrin IX photobleaching during the light irradiation phase of standard dermatological methyl-aminolevulinate photodynamic therapy. Abstract
Hopper, Colin	University College Hospital	09/09/2010	2.52	Photodiagnosis and photodynamic therapy Optical coherence tomography-guided photodynamic therapy for skin cancer: case study. Abstract
Curnow, A	Royal Cornwall Hospital	08/06/2010	2.52	Photodiagnosis and photodynamic therapy Effect of MAL-photodynamic therapy on hypertrophic scarring. Abstract
Curnow, Alison	Royal Cornwall Hospital	04/24/2010	2.52	Photodiagnosis and photodynamic therapy Validation of a non-invasive fluorescence imaging system to monitor dermatological PDT. Abstract
Robinson, Dominic J	Department of Dermatology, Erasmus MC, Rotterdam, The Netherlands.	02/18/2010	2.52	Photodiagnosis and photodynamic therapy A dedicated applicator for light delivery and monitoring of PDT of intra-anal intraepithelial neoplasia. Abstract
Huang, Zheng	Shanghai Skin Diseases and STD Hospital	02/07/2010	2.52	Photodiagnosis and photodynamic therapy Topical ALA PDT for the treatment of severe acne vulgaris. Abstract
Hamblin, Michael R	Massachusetts General Hospital	11/25/2009	2.52	Photodiagnosis and photodynamic therapy Photodynamic therapy for localized infections--state of the art. Abstract
Huang, Zheng	Shanghai Skin Diseases and STD Hospital	09/10/2009	2.52	Photodiagnosis and photodynamic therapy Photodynamic therapy in treatment of port wine stain birthmarks--recent progress. Abstract
Li, Xuejun	Peking University	02/21/2012	2.52	European journal of pharmacology Atorvastatin synergizes with IFN-γ in treating human non-small cell lung carcinomas via potent inhibition of RhoA activity. Abstract
Sonenberg, N		02/20/2009	2.47	Current oncology (Toronto, Ont.) Targeting mTOR-dependent tumours with specific inhibitors: a model for personalized medicine based on molecular diagnoses. Abstract
Gu, Ying	PLA General Hospital	08/24/2013	2.42	Lasers in medical science Assessment of tissue perfusion changes in port wine stains after vascular targeted photodynamic therapy: a short-term follow-up study. Abstract
Curnow, A	Royal Cornwall Hospital	08/28/2012	2.42	Lasers in medical science Effect of an oxygen pressure injection (OPI) device on the oxygen saturation of patients during dermatological methyl aminolevulinate photodynamic therapy. Abstract
Gu, Ying	PLA General Hospital	02/16/2011	2.42	Lasers in medical science Influence of laser wavelength on the damage of comb's vasculature by photodynamic therapy--simulation and validation of mathematical models. Abstract
Huang, Zheng	Shanghai Skin Diseases and STD Hospital	02/26/2009	2.42	Lasers in medical science Treatment of perianal Paget's disease using photodynamic therapy with assistance of fluorescence examination: case report. Abstract
Hasan, Tayyaba	Harvard Medical School	04/04/2013	2.41	Photochemistry and photobiology PDT dose parameters impact tumoricidal durability and cell death pathways in a 3D ovarian cancer model. Abstract
Hamblin, Michael R	Massachusetts General Hospital	02/19/2013	2.41	Photochemistry and photobiology Linezolid and vancomycin decrease the therapeutic effect of methylene blue-photodynamic therapy in a mouse model of MRSA bacterial arthritis. Abstract
Huang, Zheng	Shanghai Skin Diseases and STD Hospital	01/10/2012	2.41	Photochemistry and photobiology Treatment of HPV infection-associated cervical condylomata acuminata with 5-aminolevulinic acid-mediated photodynamic therapy. Abstract
Curnow, Alison	Royal Cornwall Hospital	09/16/2011	2.41	Photochemistry and photobiology An in vitro comparison of the effects of the iron-chelating agents, CP94 and dexrazoxane, on protoporphyrin IX accumulation for photodynamic therapy and/or fluorescence guided resection. Abstract
Hamblin, Michael R	Massachusetts General Hospital	02/22/2011	2.41	Photochemistry and photobiology Analysis of the bacterial heat shock response to photodynamic therapy-mediated oxidative stress. Abstract
Robinson, Dominic J	Department of Dermatology, Erasmus MC, Rotterdam, The Netherlands.	11/05/2010	2.41	Photochemistry and photobiology Fractionated illumination at low fluence rate photodynamic therapy in mice. Abstract
Curnow, Alison	Royal Cornwall Hospital	11/05/2010	2.41	Photochemistry and photobiology The hydroxypyridinone iron chelator CP94 can enhance PpIX-induced PDT of cultured human glioma cells. Abstract
Wulf, Hans Christian	University of Copenhagen	11/03/2009	2.41	Photochemistry and photobiology Vitamin D level in summer and winter related to measured UVR exposure and behavior. Abstract
Korbelik, Mladen	British Columbia Cancer Agency, Vancouver, BC	10/09/2013	2.40	International journal of oncology Increased killing of SCCVII squamous cell carcinoma cells after the combination of Pc 4 photodynamic therapy and dasatinib is associated with enhanced caspase-3 activity and ceramide synthase 1 upregulation. Abstract
Korbelik, M	Wayne State University	12/06/2010	2.40	International journal of oncology Enhanced tumor cures after Foscan photodynamic therapy combined with the ceramide analog LCL29. Evidence from mouse squamous cell carcinomas for sphingolipids as biomarkers of treatment response. Abstract
Korbelik, Mladen	British Columbia Cancer Agency, Vancouver, BC	10/08/2010	2.38	International immunopharmacology Expression of complement and pentraxin proteins in acute phase response elicited by tumor photodynamic therapy: the engagement of adrenal hormones. Abstract
Blenis, John	Harvard Medical School	05/20/2013	2.18	Molecules and cells Nutrient regulation of the mTOR complex 1 signaling pathway. Abstract
Hengstschläger, Markus	Medical University of Vienna	07/01/2012	2.17	Organogenesis Amniotic fluid stem cells to study mTOR signaling in differentiation. Abstract
Li, Xianliang	Sun Yat-Sen University	09/03/2009	2.11	Neuroscience letters Atorvastatin attenuates NF-kappaB activation in trigeminal nucleus caudalis in a rat model of migraine. Abstract
Hamblin, Michael R	Massachusetts General Hospital	08/13/2012	2.07	Expert review of clinical immunology Photodynamic therapy induces an immune response against a bacterial pathogen. Abstract
Hamblin, Michael R	Massachusetts General Hospital	12/17/2010	2.07	Expert review of clinical immunology Stimulation of anti-tumor immunity by photodynamic therapy. Abstract